Page last updated: 2024-12-04

eritadenine

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth

Description

eritadenine: isolated from Lentinula edodes (Shiitake mushroom); inhibits S-adenosyl-L-homocysteine hydrolase activity [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID159961
CHEMBL ID1095280
SCHEMBL ID308656
MeSH IDM0262420

Synonyms (30)

Synonym
9h-purine-9-butanoic acid, 6-amino-alpha,beta-dihydroxy-, (r-(r*,r*))-
erythronic acid, 4-(6-amino-9h-purin-9-yl)-4-deoxy-, d-
d-eritadenine
lentinacin
lentysine
DB03769
eritadenine
CHEMBL1095280 ,
bdbm50316222
(2r,3r)-4-(6-aminopurin-9-yl)-2,3-dihydroxybutanoic acid
23918-98-1
A820627
(2r,3r)-4-(6-aminopurin-9-yl)-2,3-bis(oxidanyl)butanoic acid
unii-41t27k4b9f
41t27k4b9f ,
4-(9-adenyl)-d-erythro-2,3-dihydroxybutyric acid
eritadenine [mi]
9h-purine-9-butanoic acid, 6-amino-.alpha.,.beta.-dihydroxy-, (.alpha.r,.beta.r)-
4-(6-aminopurin-9-yl)-4-deoxy-d-erythronic acid
4-(6-amino-9h-purin-9-yl)-4-deoxy-d-erythronic acid
SCHEMBL308656
DTXSID00178632
AKOS030254737
J-015277
mmv689255
(2r,3r)-4-(6-amino-9h-purin-9-yl)-2,3-dihydroxybutanoic acid
Q15410938
leutinacin
sr-05000022549
SR-05000022549-1

Research Excerpts

Toxicity

ExcerptReferenceRelevance
" An animal model (where male and female rats were administered 21 and 10 mg per kg animal per day of eritadenine) indicated that intake of the compound was safe under these concentrations; it reached the liver and reduced the atherogenic index (TC/HDL) in rat sera."( Effect of traditional and modern culinary processing, bioaccessibility, biosafety and bioavailability of eritadenine, a hypocholesterolemic compound from edible mushrooms.
Largo, C; Morales, D; Piris, AJ; Polo, G; Soler-Rivas, C; Tabernero, M, 2018
)
0.48

Bioavailability

ExcerptReferenceRelevance
" Since most efforts have focused on the development of nucleoside analog inhibitors, issues regarding bioavailability and selectivity have been major challenges."( A new structural class of S-adenosylhomocysteine hydrolase inhibitors.
Chun, TG; Kim, BG; Lee, HY; Snapper, ML, 2009
)
0.35
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Protein Targets (1)

Inhibition Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
AdenosylhomocysteinaseRattus norvegicus (Norway rat)IC50 (µMol)0.03000.03000.03000.0300AID477479
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Molecular Functions (1)

Processvia Protein(s)Taxonomy
adenosylselenohomocysteinase activityAdenosylhomocysteinaseRattus norvegicus (Norway rat)
[Information is prepared from geneontology information from the June-17-2024 release]

Ceullar Components (1)

Processvia Protein(s)Taxonomy
cytosolAdenosylhomocysteinaseRattus norvegicus (Norway rat)
[Information is prepared from geneontology information from the June-17-2024 release]

Bioassays (1)

Assay IDTitleYearJournalArticle
AID477479Inhibition of S-adenosyl-L-homocysteine hydrolase in intact rat hepatocytes2009Bioorganic & medicinal chemistry, Sep-15, Volume: 17, Issue:18
A new structural class of S-adenosylhomocysteine hydrolase inhibitors.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (30)

TimeframeStudies, This Drug (%)All Drugs %
pre-19904 (13.33)18.7374
1990's6 (20.00)18.2507
2000's13 (43.33)29.6817
2010's5 (16.67)24.3611
2020's2 (6.67)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other30 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]